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Abstract 
 
Objectives 
Trans-diagnostic approaches suggest that key cognitive and 
behavioural processes maintain symptoms across a wide range 
of mental health disorders. Fatigue is a common clinical feature 
of Attention Deficit Hyperactivity Disorder (ADHD) in 
adulthood; however empirical data supporting its prevalence is 
lacking. This study aims to collate outcomes from outpatient 
services to 1) investigate the prevalence of fatigue in adults 
with ADHD, 2) examine symptoms of ADHD in adults with 
Chronic Fatigue Syndrome (CFS) and 3) consider secondary 
clinical characteristics common to both disorder groups. 
 
Methods 
Measures of self-reported fatigue were compared across groups 
of adults with ADHD (N = 243), CFS (N = 86) and healthy 
controls (N = 211) using a between-subjects cross-sectional 
design. Groups were also compared on secondary clinical 
measures of functional impairment, mood, anxiety, sleep, self-
efficacy and their beliefs about the acceptability of expressing 
emotions. 
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Results 
The ADHD group were significantly more fatigued than 
healthy controls with 62% meeting the Chalder et, al. (2013) 
criteria for fatigue caseness. ADHD symptomology was 
significantly greater in the CFS group than healthy controls. 
ADHD and CFS groups did not differ significantly on measures 
of functional impairment, mood and self-efficacy. No 
significant differences were detected on measures of anxiety 
when items relating to physical restlessness were removed from 
the analysis. 
 
Conclusions 
Adults with ADHD experience greater fatigue than healthy 
controls. Adults with CFS and ADHD share many trans-
diagnostic clinical characteristics, including difficulties with 
low mood, anxiety and reduced self-efficacy which impact 
upon their overall functioning. Further research is required to 
investigate extraneous factors mediating fatigue severity in 
these clinical groups. 
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Practitioner Points 
 Fatigue is a common clinical feature of ADHD in 
adulthood 
 Evidenced-based interventions for CFS could be 
adapted to address fatigue in adults ADHD 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
Introduction 
Attention Deficit Hyperactivity Disorder (ADHD) is a 
neurodevelopmental disorder characterised by behavioural 
symptoms of inattention, hyperactivity and impulsivity present 
before the age of 12 (DSM-5; American Psychiatric 
Association, 2013). Prevalence rates of ADHD in adulthood are 
estimated at 3.5% cross-nationally (de Graaf et al., 2008) and 
associated with moderate to severe levels of functional 
impairment in academic(Birchwood & Daley, 2012),  
occupational (Biederman et al., 2006; Halmøy, Fasmer, 
Gillberg, & Haavik, 2009) and social domains (Ramirez et al., 
1997; Sacchetti & Lefler, 2014; Shaw-Zirt, Popali-Lehane, 
Chaplin, & Bergman, 2005). 
Coping with ADHD in adulthood can be cognitively demanding 
as considerable mental effort is required to ignore 
environmental distractors, sustain attention, control impulsive 
urges and manage internal restlessness (Barkley, 2014). Many 
have experienced chronic underachievement and continuous 
negative feedback from others due to difficulties with symptom 
management (Young, Braham, Gray & Rose, 2007). As a result, 
reports of low self-esteem and reduced self-efficacy are 
common in adulthood (Knouse & Safren, 2010; Newark, 
Elsasser, & Stieglitz, 2016; Tabassam & Grainger, 2002; 
Young, Bramham, Gray, & Rose, 2007). Evidence suggests that 
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adults with ADHD are up to eight times more likely to report a 
co-morbid mood, anxiety or substance misuse disorder (Kessler 
et al., 2006). As a result, it is perhaps unsurprising that many 
adults with ADHD present with clinically significant fatigue. 
A modest survey including 70 adults with ADHD revealed that 
almost 54% had a history of fatigue (Young & Saal, 2012). 
These prevalence rates far exceed those of 18% found in 
primary care settings (Pawlikowska et al., 1994). Reports of 
fatigue and day-time tiredness are more common in adults with 
ADHD than children or adolescents with the disorder (Fisher et 
al., 2014). Approximately 50% of adults who meet criteria for 
ADHD also meet criteria for Sluggish Cognitive Tempo 
disorder (SCT); a disorder characterised by symptoms of 
inattention, persistent daydreaming, sluggish-lethargic 
behaviour and hypoactivity (Barkley, 2012). It has also been 
suggested that adults with ADHD experience greater fatigue 
after cognitively demanding tasks, such as driving (Reimer, 
D'Ambrosio, Coughlin, Fried, & Biederman, 2007). While 
emerging evidence suggests that fatigue is a common 
associated-difficulty of ADHD in adulthood, its prevalence has 
not yet been adequately investigated. 
Fatigue has, however, been investigated in adults with a wide 
range of psychiatric and neurological disorders (Chaudhuri & 
Behan, 2004; Fukuda et al., 1994; Targum et al., 2014). 
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Medically unexplained fatigue that persists for longer than six 
months and is present more than 50% of the time, accompanied 
by significant functional impairment and psychological 
distress, satisfies criteria for Chronic Fatigue Syndrome (CFS) 
(Sharpe et al., 1991). In addition to fatigue, CFS includes 
additional somatic symptoms (e.g. dizziness, pain) and 
excessive or disproportionate thoughts, feelings and 
behaviours. As with ADHD, a high proportion of adults with 
CFS also experience co-morbid anxiety and mood-related 
disorders (Afari & Buchwald, 2003; Wessely, Chalder, Hirsch, 
Wallace, & Wright, 1997). 
Prevalence rates of ADHD in CFS have been estimated at 
almost 21%, almost six times higher than those observed in the 
general population (de Graaf et al., 2008; Saez-Francas et al., 
2012). Studies have identified excessive energy in childhood as 
a potential risk factor for developing fatigue in adulthood 
(Harvey, Wadsworth, Wessely, & Hotopf, 2008; Harvey, 
Wessely, Kuh, & Hotopf, 2009). Hence, children diagnosed 
with ADHD hyperactive/impulsive subtype may be particularly 
at risk of fatigue as they grow older. Saez-Francas and 
colleagues (2012) found that CFS patients with co-morbid 
ADHD had earlier fatigue onset, more severe anxiety and 
depression and were at higher risk of suicide than those without 
ADHD co-morbidity. Rates of suicide are also higher in CFS 
than the general population (Roberts, Wessely, Chalder, Chang, 
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& Hotopf, 2016).  In light of this, further research is required to 
better understand the trans-diagnostic processes which underlie 
this high risk subgroup of patients. 
Trans-diagnostic approaches propose that fundamental 
cognitive (e.g. attention, memory, reasoning, thoughts) and 
behavioural (e.g. experiential avoidance) processes underlie a 
wide range of mental health disorders (Harvey, Watkins, 
Mansell & Shafran, 2004; Hayes, Wilson, Gifford, Follette & 
Strosahl, 1996). Viewing different disorders through a shared 
trans-diagnostic lens highlights common processes which 
maintain symptoms across disorder groups. The Research 
Domain Criteria (RDoC) project highlights that dysfunctions in 
certain behavioural functions and neural circuits (e.g. working 
memory, emotion regulation) are common across many 
disorder groups listed in the DSM or the International 
Classification of Diseases and Related Health Problems (ICD). 
RDoC advocate for an empirically-validated, dimensional 
approach to disorder classification (Cuthbert & Insel, 2013). 
Adopting a trans-diagnostic approach is one way of  
understanding psychiatric co-morbidity, facilitating 
transference of knowledge between new and established 
disorders and advancing developments in trans-diagnostic 
treatments (Mansell, Harvey, & Shafran, 2008). 
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Developing trans-diagnostic treatments not only facilitates the 
generalisation of treatment benefits across disorder groups in a 
more cost-effective manner, it also aids the development of 
more flexible treatment protocols for research purposes 
(McEvoy, Nathan, & Norton, 2009). Hence, evidence-based 
cognitive-behavioural therapy (CBT) interventions proven to be 
effective in reducing fatigue and psychological distress in CFS 
(Deale, Chalder, Marks, & Wessely, 1997; Prins et al., 2001; 
Quarmby, Rimes, Deale, Wessely, & Chalder, 2007; Sharpe et 
al., 1996; White et al., 2011) could be adapted to target fatigue 
in adults with ADHD. Whilst consideration of all of the trans-
diagnostic processes underlying CFS and ADHD is beyond the 
scope of this study, a proportion of their shared clinical 
characteristics will be considered. 
Many adults with ADHD present with significant cognitive 
difficulties, particularly in areas of complex attention, 
executive functioning, processing speed and memory (Hervey, 
Epstein, & Curry, 2004; Woods, Lovejoy, & Ball, 2002). Many 
adults with CFS also present with impairments in these areas 
(DeLuca, Johnson, Beldowicz, Natelson, 1995; DeLuca, 
Johnson, Ellis & Natelson, 1997; Tiersky, Johnson, Lange, 
Natelson & DeLuca, 1997; Cockshell & Mathias, 2013). 
Attentional processes, such as hyper-vigilance and attentional 
avoidance, have been hypothesised to play an active causal role 
in the maintenance of a variety of psychological disorders 
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(Mansell et al., 2008). Individuals with a particular disorder 
may selectively over-attend (hypervigilance) or ignore (avoid) 
stimuli which relate to their primary concerns. In terms of 
hypervigilance, studies have shown that adults with CFS 
perceive exertion at lower heart rates than matched controls 
during exercise tasks (Gibson, Carroll, Clague, & Edwards, 
1993) and respond more quickly to health threat-related words, 
such as ‘collapse’ and ‘hospitalisation’ on the Visual Probe Task 
(Hou et al., 2014). Clinical reports of hyperfocus on very 
stimulating or rewarding tasks are also common amongst adults 
with ADHD. Clinical reports of ‘boom and bust’ behavioural 
patterns are also frequent in both groups, characterised by over-
exertion and excessive rest in adults with CFS and extremes of 
behavioural impulsivity and task-avoidance in adults with 
ADHD. 
Sleep-related difficulties have also been identified as a trans-
diagnostic process common to many psychiatric disorders, 
contributing not only to symptom onset, but also relapse and 
symptom maintenance (Harvey, 2008). Sleep disorders take 
many forms including insomnia, hypersomnia, delayed sleep 
phase and nocturnal panic attacks (Harvey, 2008; Harvey, 
Murray, Chandler, & Soehner, 2011). Once considered an 
epiphenomenon, insomnia is now regarded as a fundamental 
factor in the aetiology and maintenance of many psychiatric 
disorders (Harvey, 2008). Sleep problems have long been 
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associated with ADHD, such that disrupted sleep was 
previously a diagnostic criterion until its removal from the 
DSM-III (DSM-III; American Psychiatric Association, 1987). 
Studies have shown significantly higher prevalence rates of 
delayed sleep phase syndrome and sleep-onset insomnia in 
adults with ADHD (Bijlenga et al., 2013; Fisher et al., 2014; 
Van Veen, Kooij, Boonstra, Gordijn, & Van Someren, 2010). 
Subjective and objective sleep disorders are also common in 
CFS (Buchwald, Pascualy, Bombardier, & Kith, 1994; Krupp, 
Jandorf, Coyle, & Mendelson, 1993; Morriss et al., 1993). 
Hence, poor sleep may exacerbate core symptoms and 
associated-difficulties of ADHD and CFS. Further 
consideration of their trans-diagnostic processes may illuminate 
the nature of fatigue in adult ADHD. 
Whilst each disorder represents a heterogeneous group, a 
number of shared trans-diagnostic processes are evident in 
terms of fatigue, mood, cognitive and sleep-related difficulties 
(see figure 1). To the authors’ knowledge, trans-diagnostic 
processes in adult ADHD and CFS have not yet been 
investigated in a UK outpatient setting. Primarily, this study 
aims to investigate the prevalence of fatigue in an adult ADHD 
population and the prevalence of ADHD symptomology (i.e. 
inattention, hyperactivity and impulsivity) in an adult CFS 
population. Trans-diagnostic processes underlying both clinical 
groups will also be investigated using self-report measures of 
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mood, anxiety, functional impairment, sleep, self-efficacy and 
participant’ beliefs about the acceptability of expressing 
emotions. It is hypothesised that ADHD participants will report 
significantly higher levels of self-reported fatigue and CFS 
participants will report significantly greater levels of ADHD 
symptomology than healthy controls. ADHD and CFS groups 
will not differ significantly on secondary trans-diagnostic 
measures. 
 
Methods 
 
Participants 
Participants were recruited from adult ADHD (N=211) and CFS 
(N= 86) outpatient services, where participants were attending 
Cognitive-Behavioural Therapy (CBT). A convenience sample 
of staff and students from a local university were also recruited 
to form a healthy control comparison group (N = 243). 
Participants were excluded using the following criteria; verbal 
IQ < 80, non-fluent in English, presence of a primary mood, 
psychosis, personality or pervasive developmental disorder, 
current risk to self or others, active substance 
misuse/dependence within the last three months or history of an 
acquired brain injury. 
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ADHD participants were assessed by a consultant psychiatrist 
experienced in diagnosing ADHD in adulthood. DSM-IV 
criteria were established using a structured diagnostic 
interview, as these were the most up-to-date DSM criteria 
available at the time of the stud. Collateral information was 
obtained from an informant to confirm childhood onset of 
symptoms as suggested in diagnostic guidelines (National 
Collaborating Centre For Mental Health, 2008). A psychiatric 
assessment was also conducted to exclude any other organic or 
psychiatric causes of ADHD symptoms. CFS participants were 
assessed by a physician or CBT therapist experienced in 
diagnosing CFS. CFS participants met CDC or Oxford criteria 
for CFS, established using a semi-structured diagnostic 
interview and a medical screening examination to exclude any 
other organic or psychiatric causes of fatigue as outlined in 
diagnostic guidelines (Sharpe, Chalder, Palmer, & Wessely, 
1997; Sharpe et al., 1991). 
 
Procedure 
Questionnaires and instructions for completion were posted to 
participants alongside additional pre-therapy outcome measures 
routinely obtained prior to client’s engagement with CBT. 
Completion of measures listed in this study is estimated to have 
taken participants between 20 - 30 minutes. Data was included 
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where participants provided written consent allowing their 
measures to be included in future audits and research projects 
within each service. Participants returned questionnaires to 
clinicians during therapy sessions. Reminders were provided by 
clinicians as necessary to support data collection. Information 
regarding the return rate is unfortunately unavailable; however 
it is estimated that most participants attending CBT completed 
their measures as this is part of pre-therapy standard clinical 
procedures.  
 
Measures  
 
Demographic and clinical characteristics 
Information regarding the participants’ demographic 
characteristics (age, gender, ethnicity, relationship status, 
education level) was obtained using a self-report measure. 
Participants were also asked to declare any previous episodes 
of fatigue which warranted GP attention as well as the presence 
of any current physical or mental health concerns. 
 
Chalder Fatigue Scale (CFS; Cella & Chalder, 2010; Chalder 
et al., 1993)  
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This is an 11 item self-report measure of physical and mental 
fatigue. Participants rate fatigue experienced over the past 
month compared to their usual energy levels using a four point 
Likert scale, where 0 = ‘less than usual’ and 3 = ‘much more 
than usual’. Scores range from zero to 33. A bimodal version 
can also be calculated, where scores range from 0-11, with a 
cut-off score of four or more indicating fatigue caseness. The 
CFS has excellent consistency with a Cronbach’s alpha of 0.95 
in the current sample. 
 
Barkley’s Current Symptom Scale (Barkley & Murphy, 2006) 
This is an 18 item self-report measure denoting ADHD 
diagnostic criteria as outlined in the DSM-IV (American 
Psychiatric Association, 2000). Items assess the frequency of 
nine inattentive symptoms and nine hyperactive and impulsive 
symptoms. Participants rate the frequency of each symptom on 
a four point Likert scale, where 0 = never and 3 = often. Scores 
range from zero to 54. A score of two or more on each item is 
indicative of symptom presence. A cut-off point of six or more 
items in each domain is suggestive of clinically significant 
inattention or hyperactivity and impulsivity. This measure has 
strong reliability and validity and it has been widely used in 
ADHD research. In the current study, internal consistency for 
each subscale was excellent (inattention = 0.97, hyperactivity 
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and impulsivity = 0.95). 
 
Work and Social Adjustment Scale (WASA; Mundt, Marks, 
Shear, & Greist, 2002) 
 This is a five item self-report measure of functional 
impairment in occupational and social settings. Participants rate 
each item on a Likert scale, where 0 = not impaired at all and 8 
= very severely impaired. Scores range from zero to 40. A 
reduction of 8-points or more is suggestive of a clinically 
significant improvement (Zahra et al., 2014). The WASA is a 
reliable and valid measure which has been widely used to 
assess functionality in relation to a number of different 
disorders (Cella, Sharpe, & Chalder, 2011; Mataix-Colsa et al., 
2005). This scale has excellent internal consistency in the 
current sample with a reported Cronbach’s alpha of 0.94. 
 
Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983)  
This measure comprises of 14 items, where seven items 
measure symptoms of anxiety and seven items measure 
symptoms of depression. Scores ranging from 0 – 7 fall within 
the ‘Normal’ range, 8 – 10 ‘Mild’ range, 11 – 14 ‘Moderate’ 
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range and 15 – 21 ‘Severe’ range. A mean Cronbach’s alpha co-
efficient of .83 has been reported for the anxiety subscale and 
.82 for the depression subscale. The HADS is an effective tool 
for assessing symptom severity in anxiety and somatic 
disorders in psychiatric and primary care settings as well as in 
the general population (Bjellanda, Dahlb, Haugc, & 
Neckelmannd, 2002). Internal consistency for both subscales 
was good in the current population (anxiety = 0.89, depression 
= 0.83). 
 
Jenkins Sleep Evaluation Questionnaire (JSEQ; Jenkins, 
Stanton, Niemcryk, & Rose, 1988)  
 This measure comprises of four items rated on a six-point 
scale.  Items ask how frequently during the previous four weeks 
the respondent has experienced 1) difficulty falling asleep, 2) 
difficulty staying asleep, 3) waking up several times per night 
and 4) waking up feeling tired and worn out after the usual 
amount of sleep. Response options include; 0 = not at all, 1 = 1 
- 3 days, 2 = 4 - 7 days, 3 = 8 - 14 days, 4 = 15 - 21 days and 5 
= 22 - 28 days. Scores range from 0 – 20, where higher scores 
are suggestive of a greater number of sleep problems. This 
scale also has acceptable internal consistency with Cronbach’s 
alphas ranging from of 0.63 – 0.79 in cardiac and fibromyalgia 
patients (Crawford, Piault, Lai, & Sarzi-Puttini, 2010) as well 
19 
 
0.78 in the current sample. 
 
Generalised Self-efficacy Scale (GSE; Schwarzer & Jerusalem, 
1995)  
This measure is a 10 item scale measuring the respondent’s 
capability to handle new and difficult tasks in a variety of 
different domains. Responses are rated on a four point scale, 
where 1 = not at all true, 2 = hardly true, 3 = moderately true 
and 4 = exactly true. Scores range from 10 – 40 with higher 
scores indicating greater self-efficacy. This measure has been 
validated cross-nationally, with Cronbach alphas range from 
0.86 – 0.94 in patients with cardiovascular disease, cancer, 
gastrointestinal disease and healthy controls (Luszczynska, 
Scholz, & Schwarzer, 2005). Cronbach’s alpha in the current 
sample was 0.92. 
 
Beliefs about Emotions (BAE; Rimes & Chalder, 2010) 
This is a 12-item self-report scale measuring beliefs about the 
unacceptability of experiencing and expressing emotion. Items 
are rated on a seven point Likert scale, where 0 = totally agree 
and 7 = totally disagree. Higher scores represent more 
maladaptive beliefs. The BAE has good internal consistency 
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with Cronbach’s alphas of 0.91 in individuals with CFS and 
0.90 in the current sample. 
 
Statistical analysis 
Statistical analysis was performed using the IBM Statistical 
Package for the Social Sciences version 22.0. As assumptions 
of normality were violated, non-parametric analyses were used. 
Missing items were replaced with mean scores and where more 
than 25% of items were missing data was excluded. However, 
it is noteworthy that greater than 98% of the overall sample 
completed over 75% of items on each measure. All significance 
test results are quoted as two-tailed and significance levels of 
.05 are reported for all tests, unless otherwise specified. 
Chi-square analyses were performed to investigate differences 
between CFS, ADHD and HC groups on demographic and 
clinical characteristics, with the exception of age which was 
investigated using a Kruskal Wallis test.   
Between-group differences on measures of fatigue, ADHD 
symptomology, mood, anxiety, functional impairment, sleep, 
self-efficacy and beliefs about emotions were investigated 
using multiple Kruskal Wallis tests. A further Kruskal Wallis 
test was performed on the HADS anxiety subscale with items 
A1, A4 and A6 removed to control for physical restlessness as a 
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possible confounding variable with ADHD symptomology.  
Adjusted significance values were interpreted to account for 
multiple comparisons across the three participant groups. The 
percentage of participants in each group meeting criteria for 
caseness in fatigue, depression, anxiety, inattention and 
hyperactivity or impulsivity were compared using chi square 
analyses. 
 
Ethical approval 
Ethical approval was received from the relevant local 
committee. The nature and purpose of the study was fully 
explained to participants prior to obtaining informed consent.   
 
Results 
 
Demographic characteristics 
Results illustrate that CFS (N = 86), ADHD (N = 204) and HC 
(N = 243) groups differed significantly across demographic and 
clinical characteristics. Medians (Mdn), interquartile ranges 
(IQR) and test statistics for Kruskal Wallis and chi square 
analyses are reported in table 1. Adjusted significance values 
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are reported for Kruskal Wallis post-hoc analyses to account for 
multiple comparisons. 
A significant difference in age was found across CFS, ADHD 
and HC groups, however post-hoc analyses failed to detect any 
significant pairwise comparisons. Significant gender 
differences were also observed across participant groups, with 
70% of the ADHD group comprising of males compared with 
only 27% of CFS and HC groups respectively. The ADHD 
group were more ethnically diverse, with 23% identifying as 
other than white British, compared with 19% of CFS and 8% of 
HC groups. ADHD and CFS groups were similar in terms of 
education and relationship status, with approximately half of 
each group educated to University level and a third identifying 
as married or living together. This contrasted with the HC 
group, of whom a greater proportion was educated to 
University level (88%) and married or living together (52%). 
 
Clinical characteristics 
Forty-five percent of ADHD participants declared that they had 
previously experienced an episode of fatigue that warranted GP 
attention, compared with only 17% of HC participants. Recent 
reports of physical and mental health concerns were more 
common in patient groups than HC. CFS participants (34%) 
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were more likely to present with a current physical health 
concern than ADHD participants (23%). Approximately half of 
both patient groups reported current mental health problems. 
 
Between-groups comparisons for fatigue 
A significant range of fatigue scores were observed within an 
across participants groups (see figure 1). Kruskal-Wallis tests 
demonstrated a significant between-groups difference for 
fatigue. Post-hoc comparisons revealed that the ADHD group 
reported significantly lower levels of fatigue than the CFS 
group. However the ADHD group did report significantly 
higher levels of fatigue than controls. This pattern was also 
observed for both the physical and mental fatigue subscales 
(see table 2). 
Results of a chi square analysis detected a significant difference 
between participant groups regarding the percentage of 
participants meeting the Chalder et al. (2013) criteria for 
fatigue caseness. The ADHD group (62%) had fewer 
participants meeting caseness for fatigue than the CFS group 
(86%), however the ADHD group had considerably more 
participants meeting criteria than the HC group (26%). 
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Between-groups comparisons for ADHD symptomatology 
Kruskal-Wallis tests demonstrated a significant between-groups 
difference for ADHD symptomology. Perhaps unsurprisingly, 
post-hoc analyses revealed significantly higher Barkley scores 
in the ADHD group than in either comparison group. However, 
interestingly, the CFS group also obtained significantly higher 
ADHD scores than controls. 
A chi-square test revealed a significant difference between 
ADHD, CFS and HC groups in terms of the percentage 
participants in each group meeting criteria for symptom 
presence (i.e. positive responses to 6 out of 9 criteria in each 
domain). Seventy-three percent of ADHD participants met 
criteria for inattention symptom presence, compared with 12% 
of CFS and 0% of controls. A lesser proportion of ADHD 
participants met criteria for hyperactivity and impulsivity 
symptom presence (44%) compared with only 6% of CFS and 
0% of controls. 
Between-groups comparisons for trans-diagnostic measures 
A further series of Kruskal-Wallis tests detected significant 
between-group differences across all secondary clinical 
measures (see table 4). 
There were no significant post-hoc differences between the 
ADHD and CFS groups on the HADS depression scale; 
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however both patient groups reported significantly higher 
levels of depression than controls. A similar proportion of 
patients in the ADHD and CFS groups reported mild symptoms 
of depression or higher (46% and 48% respectively). These 
rates were considerably higher than those observed in the 
control group (8.5%). 
Post-hoc analyses revealed significantly higher HADS anxiety 
scores in the ADHD group than the CFS group, with both 
patient groups reporting significantly higher anxiety than the 
HC group. Seventy-nine percent of ADHD participants reported 
mild symptoms of anxiety or higher, compared with 56% and 
29% of CFS and controls. 
Group HADS anxiety scores were again compared with 
confounding items relating to physical restlessness as a 
confounding ADHD symptomology variable (e.g. item A1 ‘I 
feel tense of “wound up”’) omitted. Post-hoc analyses failed to 
detect a significant difference between ADHD and CFS groups; 
however both clinical groups continued to report significantly 
higher scores than controls. 
 There were no significant post-hoc differences between the 
ADHD and CFS groups on measures of functional impairment 
and self-efficacy, with both patients groups significantly more 
impaired than controls. 
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Post-hoc analyses revealed a significantly higher number of 
sleep–related difficulties in the CFS group than the ADHD 
group, with both patient groups reporting significantly more 
sleep-related difficulties than controls. 
The ADHD group reported significantly higher scores than CFS 
group on the beliefs about emotions measure; however no 
significant differences were detected between the CFS group 
and controls. 
 
Discussion 
 
This study primarily aimed to investigate the prevalence of 
fatigue in an adult ADHD outpatient population. Whilst many 
studies have focused on sleep-related difficulties in adult 
ADHD (Bijlenga et al., 2013; Fisher et al., 2014; Philipsen, 
Hornyak, & Riemann, 2006; Van Veen, Kooij, Boonstra, 
Gordijn, & Van Someren, 2010), there has been a dearth of 
research investigating fatigue. Results suggest that fatigue is 
significantly greater in adults with ADHD than healthy 
controls. This trend was observed for both physical and mental 
fatigue, with 63% of ADHD participants meeting the Chalder et 
al. (2013) criteria for fatigue caseness. Whilst the chronicity of 
fatigue was not formally assessed in this study, 45% of 
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participants in the ADHD group reported having previously 
experienced an episode of fatigue that warranted GP attention. 
Fatigue prevalence rates reported here are comparable with 
those from a brief survey carried out with adults with ADHD 
(Young & Saal, 2012) and vastly exceed those of fatigue 
reported in primary care settings (Pawlikowska et al., 1994; 
Wessely, Chalder, Hirsch, Wallace, & Wright, 1997). Hence, 
initial results suggest that fatigue is a common yet under-
recognised clinical feature of ADHD in adulthood. 
In comparison with the CFS group, the ADHD group were 
significantly less fatigued. Although fatigue is the primary 
concern of those with CFS and regarded as an epiphenomenon 
in ADHD, sleep problems were significantly higher in the CFS 
group and as such this finding may have been a confounding 
variable as links between sleep-related difficulties and day-time 
fatigue are well-recognised in this group (Buchwald, Pascualy, 
Bombardier, & Kith, 1994; Krupp, Jandorf, Coyle, & 
Mendelson, 1993; Morriss et al., 1993). Hence, discrepancies 
noted between CFS and ADHD groups in this study cannot be 
assumed to reflect differences in fatigue alone.  
The secondary aim of this study was to investigate the 
prevalence of ADHD symptomology (i.e. inattention, 
hyperactivity and impulsivity) in adults with CFS. Almost 12% 
of the CFS group reported symptoms of inattention reaching 
28 
 
clinical significance and 6% reported symptoms of 
hyperactivity and impulsivity reaching clinical significance.  
These scores are considerably lower than those detected in the 
ADHD group (73% and 44% respectively); however they 
vastly exceed those found in the control group (less than 1%). 
Although other studies have observed prevalence rates of up to 
21% in the CFS population (de Graaf et al., 2008; Saez-Francas 
et al., 2012), self-report measures of ADHD symptomology 
cannot be assumed diagnostic when considered in isolation. 
Self-report measures form only one part of a comprehensive 
adult ADHD assessment according to diagnostic guidelines. 
Nonetheless, self-report scores reported here suggest that 
attentional difficulties are more prevalent in the CFS group 
than the control group. These results are in-keeping with 
reports of attention and information processing speed 
difficulties noted in the wider CFS literature (DeLuca, Johnson, 
Beldowicz, Natelson, 1995; DeLuca, Johnson, Ellis & 
Natelson, 1997; Tiersky, Johnson, Lange, Natelson & DeLuca, 
1997; Cockshell & Mathias, 2013).  
Lastly, this study aimed to investigate trans-diagnostic 
processes underlying ADHD and CFS. Results suggest that 
both clinical groups performed homogenously across a range of 
secondary clinical measures, including mood, functional 
impairment and self-efficacy. Approximately half of both 
clinical groups met caseness for mild depression. Initial results 
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suggest that ADHD participants were considerably more 
anxious than CFS participants; however when items relating to 
physical restlessness (e.g. I feel tense or "wound up") were 
removed due to their confounding relationship with ADHD 
symptomology, no significant differences were found between 
the two groups.  These results are consistent with rates of 
psychiatric co-morbidity found in both groups (Afari & 
Buchwald, 2003; Kessler et al., 2006; Wessely, Chalder, Hirsch, 
Wallace, & Wright, 1997) and support the hypothesis that there 
are shared trans-diagnostic processes common across disorder 
groups (Mansell, Harvey, & Shafran, 2008), shedding further 
light on why almost half of all psychological disorders are 
found to be co-morbid (Cuthbert & Insel, 2013; Kessler, Chiu, 
Demler, & Walters, 2005). 
Benefits of adopting a trans-diagnostic approach to mental 
health difficulties have been well documented, not least those 
relating to the generalisation of knowledge from established 
models to new psychological phenomena (Harvey, Watkins, 
Mansell, & Shafran, 2004; Mansell et al., 2008). Results from 
this study suggest that screening for fatigue in adult ADHD 
services would be beneficial, such that fatigue management 
information already available for other conditions (e.g. chronic 
fatigue) could be provided to clients at an early stage before 
symptoms become functionally impairing. Furthermore, where 
fatigue is deemed to be more severe, established Cognitive-
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Behavioural Therapy (CBT) treatment manuals for fatigue 
(Burgess & Chalder, 2005; Deale, Chalder, Marks, & Wessely, 
1997; Quarmby, Rimes, Deale, Wessely, & Chalder, 2007) 
could be adapted for use with adults with ADHD. These could 
help address such maintaining factors as ‘boom and bust’ 
behaviours in everyday tasks, negative self-beliefs and 
unhelpful emotional regulation strategies, such as experiential 
avoidance.  An individualised, formulation-based CBT 
approach to treating associated difficulties of ADHD in 
adulthood (Dittner, Rimes, Russell, & Chalder, 2014) would 
make it possible to target such maintaining difficulties directly.   
Likewise, CFS patients would benefit from psychoeducation 
regarding the nature of cognition and factors which affect 
memory, attention and concentration, in addition to specific 
skills training to improve inattention, hyperactivity and 
impulsivity (e.g. help with planning and organization). CFS 
patients may also benefit from therapeutic interventions which 
target negative self-beliefs that arise from difficulties with 
attention and concentration, as these beliefs may impact upon 
mood, self-efficacy and functional capabilities. 
A number of limitations must also be noted with regards to the 
findings of this study. In terms of the sample recruited, ADHD 
and CFS participants were attending national specialist services 
and therefore results may not be representative of local 
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services. Equally, groups were not matched on socio-
demographic variables (e.g. gender, age and ethnicity). 
However, clinical groups did not differ significantly in terms of 
age, educational background and relationship status. Indeed 
88% of healthy controls were university educated and hence 
their results may not reflect the distribution of cognitive and 
mood-related difficulties found in the general population. As 
questionnaires were completed by participants independently, it 
is possible that questionnaires were susceptible to fatigue 
effects and counterbalancing was not implemented. It is also 
possible that less impaired participants were more likely to 
complete and return questionnaires and hence results presented 
in this study may not be completely representative. However, it 
is noteworthy that 86% of CFS participants in this study met 
the Chalder et al. (2013) criteria for fatigue and 100% reported 
fatigue as a significant problem at the time of assessment. 
Hence CFS participants were assumed to suffer from 
significant and debilitating fatigue. 
In conclusion, there appear to be a number of trans-diagnostic 
processes common to both ADHD and CFS, as indicated by the 
results of this study. Clinical features of fatigue in addition to 
attentional, sleep and mood-related difficulties appear to be 
present to varying degrees in both clinical populations. 
Research suggests that patients meeting criteria for both 
disorders are at high risk of suicidality and mortality (Roberts, 
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Wessely, Chalder, Chang, & Hotopf, 2016; Saez-Francas et al., 
2012), hence further evaluation into fatigue in adult ADHD is 
required to meet the needs of this complex client group. 
Developments towards trans-diagnostic treatments also pose 
exponential benefits to public health and clinical service 
providers, in terms of providing cost-efficient interventions to 
meet the needs of a range of service-users across mental health 
services, whilst reducing training requirements and treatment 
waiting times (McEvoy, Nathan, & Norton, 2009). 
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Figures and tables 
 
Figure 1. Trans-diagnostic processes in adults with Attention 
Deficit Hyperactivity Disorder (ADHD) and Chronic Fatigue 
Syndrome (CFS).  
 
 
Figure 2. Total fatigue scores in participant groups
Inattention 
Executive dysfunction 
Sleep difficulties 
Low mood 
Fatigue 
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Table .1 Between-group comparisons for participant characteristics 
 
 
  
   
 HC CFS ADHD Test statistic  
Characteristic (N =243) 
) 
(N = 86) (N = 211) (df) p 
 Mdn 
 
Mdn Mdn   
 (IQR) 
 
(IQR) (IQR)   
Age 31 (14) 36 (19) 36 (14) 6.8 (2, 533) 0.033 
      
Gender N (%) N (%) N (%)   
Male 66 (27) 23 (27) 147 (70)   
Female 177 (73) 63 (73) 64 (30) 94.9 (2, 540) 0.0001 
Ethnicity      
White 224 (92) 68 (81) 143 (77)   
Other 19 (8) 16 (19) 43 (23) 20.3 (2, 513) 0.0001 
Education      
None/Secondary 14 (5.7) 16 (19) 39 (26)   
Polytechnic 16 (6.6) 20 (24) 35 (23)   
University 214 (87.7) 48 (57) 76 (51) 71.7 (4, 478) 0.0001 
Relationship status      
Single 104 (43) 50 (58) 81 (53)   
Married/Living together 127 (52) 26 (30) 57 (37)   
Other 13 (5) 10 (12) 15 (10) 17.2 (4, 483) 0.002 
Previous fatigue      
Yes 42 (17) 86 (100) 34 (45)   
No 202 (83) 0 (0) 41 (55) 182.7 (2, 405) 0.0001 
Current physical illness      
Yes 37 (15) 29 (34) 17 (23)   
No 207 (85) 56 (66) 58 (77) 14.1 (2, 404) 0.001 
Current mental health 
problem 
     
Yes 19 (8) 37 (44) 41 (55)   
N  223 (92) 47 (56) 33 (45) 92.45 (2, 400) 0.0001 
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Abbreviations: HC: healthy controls; CFS: Chronic Fatigue Syndrome; ADHD: Attention Deficit Hyperactivity Disorder; N: Number; df: 
Degrees of freedom; p: Probability value; Mdn: Median; IQR: Interquartile range. 
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Table 2. Between-groups comparisons for fatigue 
 
Subscales 
HC 
(N = 223) 
CFS 
(N = 86) 
ADHD 
(N = 76) 
Test statistic 
(df) 
 
p 
Post-hoc 
comparisons 
 Mdn Mdn Mdn    
CFS Likert Scale (IQR) (IQR) (IQR)    
Total Fatigue 11 (3) 25 (13) 16.25 (9) 131.42 (2, 385) 0.0001 CFS > ADHD > HC 
Physical Fatigue 7 (3) 17 (8) 9 (5) 120.6 (2, 385) 0.0001 CFS > ADHD > HC 
Mental Fatigue 4 (1) 8 (5) 6.5 (5) 127.92 (2, 385) 0.0001 CFS > ADHD > HC 
       
CFS Bimodal Scale N (%) N (%) N (%)    
Fatigue 
Caseness 
58/223 
(26%) 
74/86 
(86%) 
47/76 
(62%) 
 
98.9 (2, 385) 
 
0.0001  
Abbreviations: HC: healthy controls; CFS: Chronic Fatigue Syndrome; ADHD: Attention Deficit Hyperactivity Disorder; N: Number; df: 
Degrees of freedom; p: Probability value; Mdn: Median; IQR: Interquartile range.  
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Table 3. Between-groups comparisons for ADHD symptomatology 
Subscale 
HC 
(N = 223) 
CFS 
(N = 86) 
ADHD 
(N = 208) 
Test statistic 
(df) p 
Post-hoc 
comparisons 
 
Mdn 
(IQR) 
Mdn 
(IQR) 
Mdn 
(IQR)    
ADHD symptomology   0 (2) 15 (10) 33 (16) 418.87 (2, 520) 0.0001 ADHD > CFS > HC 
       
       
Caseness N (%) N (%) N (%)    
Inattention 0 (0) 10 (11.8) 104 (73.2) 25.08 (2, 454) 0.0001  
Hyperactivity/Impulsivity 0 (0) 5 (5.9) 63 (43.8) 139.20 (2, 455) 0.0001  
Abbreviations: HC: healthy controls; CFS: Chronic Fatigue Syndrome; ADHD: Attention Deficit Hyperactivity Disorder; N: Number; df: 
Degrees of freedom; p: Probability value; Mdn: Median; IQR: Interquartile range.  
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Table 4. Between-groups comparisons on trans-diagnostic measures 
 HC CFS ADHD Test statistic  Post-hoc 
Measures (N = 223) (N = 86) (N = 208) x² (df) p comparisons 
 
Mdn 
(IQR) 
Mdn 
(IQR) 
Mdn 
(IQR)    
Functional impairment 0 (2) 28 (18) 22 (18) 318.43 (2, 514) 0.0001 ADHD = CFS > HC 
Depression 2 (3) 7 (7) 7 (7) 160.47 (2, 505) 0.0001 ADHD = CFS > HC 
Anxiety 5 (5) 8.5 (7) 12 (6) 120.29 (2, 506) 0.0001 ADHD > CFS > HC 
Anxiety (physical 
restlessness items 
removed) 6 (4) 5 (5) 3 (4) 71.35 (2, 508) 0.0001 ADHD = CFS > HC 
Sleep 5 (5) 11.5 6) 9 (8) 105.32 (2, 381) 0.0001 CFS > ADHD > HC 
Self-efficacy 33 (7) 29 (4) 28 (10) 79.39 (2, 367) 0.0001 ADHD = CFS > HC 
Beliefs about emotions 34 (19) 38 (25) 40 (19) 31.68 (2, 475) 0.0001 ADHD > CFS = HC 
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Caseness N (%) N (%) N (%)    
Depression 18/212 (8.5) 41/86 (48) 96/207 (46) 84.72 (2, 505) 0.0001  
Anxiety 61/212 (29) 48/86 (56) 164/208 (79) 106.1 (2, 506) 0.0001  
Abbreviations: HC: healthy controls; CFS: Chronic Fatigue Syndrome; ADHD: Attention Deficit Hyperactivity Disorder; N: Number; x²: chi 
square value; df: Degrees of freedom; p: Probability value; Mdn: Median; IQR: Interquartile range.   
